76 – 78 of 78
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.
(
- Contribution to journal › Article
- 2012
-
Mark
Identification of serum biomarker signatures associated with pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Solitary liver lesions of indeterminate malignancy - outcome following surgical resection.
(
- Contribution to journal › Article